Overview
Our Heritage and Commitment to Regeneration
Overview
Who We Are
Forest Hills Lab is an innovative regenerative therapy company
composed of two distinct divisions specializing in Aesthetics, and
Therapeutics focused on neurodegenerative diseases.
Our global network spans offices in Hong Kong, where we are headquartered, Singapore, Korea, and the United States.
FHL Aesthetics 
FHL Aesthetics develops and markets a robust product line-up across multiple key aesthetic categories.
Consistent with the clinical rigor of our Therapeutics division, FHL Aesthetics' product offering is rooted in our medical-grade injectable Hyaluronic Acid filler solutions. Our HA filler medical device journey was among the earliest in Korea allowing us to build a base of expertise on clinical research, development and global distribution.
FHL's growing innovative medical- and cosmetic-grade aesthetics portfolio builds on that scientific and clinical base and delivers new treatment paradigms to global markets.
With a complementary portfolio developed and manufactured in-house at our Korean R&D and manufacturing facilities as well as through high-value partnerships, we directly address patient and clinician demand for higher efficacy, less treatment-related downtime, and more flexible treatment customization.
FHL Therapeutics
FHL Therapeutics is focused on developing and commercializing safe, disease-modifying therapies for devastating neurodegenerative diseases, such as Parkinson’s and Alzheimer’s Diseases. One pipeline candidate has completed Phase 1 safety trial and is preparing Phase 2 design and launch. Another is already approved by the US FDA to launch a Phase 2 trial. A third candidate is currently undergoing formulation development for intranasal administration alongside design for a Phase 1 safety trial. Clinical development is advanced on an open development platform that emphasizes external partnerships and co-development opportunities.
Contact us
- info@fhlaesthetics.com